<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01769144</url>
  </required_header>
  <id_info>
    <org_study_id>VGHKS12-CT9-09</org_study_id>
    <nct_id>NCT01769144</nct_id>
  </id_info>
  <brief_title>Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh</brief_title>
  <official_title>Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh---A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Veterans General Hospital.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bio-medical Carbon Technology Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaohsiung Veterans General Hospital.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare the effectiveness of two wound dressings, Acticoat Absorbent (AA)
      and BCT Antimicrobial (BCT) on Split Thickness Skin Graft (STSG) donor site.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Seventy patients who undergo STSG procedure in Kaohsiung Veterans General Hospital will be
      recruited. Two donor sites of equal lengths and widths on the same thigh, which are at least
      2 cm apart will be covered randomly with AA and BCT each. Wound healing rate and infection
      rate will be assessed at 7 and 14 days after surgery. Degrees of pain and itchiness will be
      assessed daily with Visual Analogue Scale for the first 7 post-operative days. Scar
      appearance will be assessed with Vancouver Scar Scale 1, 3 and 6 months post-operatively.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>wound healing rate</measure>
    <time_frame>7 days</time_frame>
    <description>percentage of wound area that has healed at this time</description>
  </primary_outcome>
  <primary_outcome>
    <measure>wound infection rate</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>wound healing rate</measure>
    <time_frame>14 days</time_frame>
    <description>percentage of wound area that has healed at this time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>scar appearance</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>1day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>scar appearance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>scar appearance</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>3 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>4 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>5 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>6 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain and itchiness</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Wound Healing</condition>
  <condition>Wound Infection</condition>
  <condition>Pain</condition>
  <condition>Pruritus</condition>
  <condition>Cicatrix</condition>
  <arm_group>
    <arm_group_label>Acticoat Absorbent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acticoat Absorbent wound dressing</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BCT wound dressing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>wound dressing</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acticoat Absorbent</intervention_name>
    <description>wound dressing</description>
    <arm_group_label>Acticoat Absorbent</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BCT</intervention_name>
    <description>wound dressing</description>
    <arm_group_label>BCT wound dressing</arm_group_label>
    <other_name>KoCarbonAg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who need STSG, longer than 8 cm and wider than 5 cm, from their thighs

        Exclusion Criteria:

          -  systemic steroid

          -  old scar on thigh

          -  systemic infection

          -  anticipated use of antibiotics for more than 24 hours after operation

          -  pregnancy

          -  previous chemotherapy within 3 months before operation

          -  anticipated chemotherapy within 3 months after operation

          -  not over 20 years old

          -  non-communicable

          -  burn area more than 20% total body surface area

          -  systemic auto-immune disease

          -  liver cirrhosis

          -  allergy to carbon fiber or alginate

          -  anticipated MRI study

          -  dry wound
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kuei-Chang Hsu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaohsiung Veterans General Hospital.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kuei-Chang Hsu, MD</last_name>
    <phone>+886-7-3422121</phone>
    <phone_ext>3073</phone_ext>
    <email>kchsu@vghks.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaohsiung Veterans General Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>81362</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kuei-Chang Hsu, MD</last_name>
    </contact>
    <investigator>
      <last_name>Kuei-Chang Hsu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>http://www.vghks.gov.tw</url>
    <description>Kaohsiung Veterans General Hospital</description>
  </link>
  <reference>
    <citation>Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns. 2000 Mar;26(2):117-30.</citation>
    <PMID>10716354</PMID>
  </reference>
  <reference>
    <citation>Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma. 2006 Mar;60(3):648-52.</citation>
    <PMID>16531870</PMID>
  </reference>
  <reference>
    <citation>Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns. 2007 Dec;33(8):979-85. Epub 2007 Oct 23.</citation>
    <PMID>17959313</PMID>
  </reference>
  <results_reference>
    <citation>Tredget EE, Shankowsky HA, Groeneveld A, Burrell R. A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998 Nov-Dec;19(6):531-7.</citation>
    <PMID>9848045</PMID>
  </results_reference>
  <results_reference>
    <citation>Argirova M, Hadjiski O, Victorova A. Acticoat versus Allevyn as a split-thickness skin graft donor-site dressing: a prospective comparative study. Ann Plast Surg. 2007 Oct;59(4):415-22.</citation>
    <PMID>17901734</PMID>
  </results_reference>
  <results_reference>
    <citation>Innes ME, Umraw N, Fish JS, Gomez M, Cartotto RC. The use of silver coated dressings on donor site wounds: a prospective, controlled matched pair study. Burns. 2001 Sep;27(6):621-7.</citation>
    <PMID>11525858</PMID>
  </results_reference>
  <results_reference>
    <citation>Huang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, Peng Y, Liu X, Luo Q. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns. 2007 Mar;33(2):161-6. Epub 2006 Dec 18.</citation>
    <PMID>17175106</PMID>
  </results_reference>
  <results_reference>
    <citation>Moiemen NS, Shale E, Drysdale KJ, Smith G, Wilson YT, Papini R. Acticoat dressings and major burns: systemic silver absorption. Burns. 2011 Feb;37(1):27-35. doi: 10.1016/j.burns.2010.09.006. Epub 2010 Oct 18.</citation>
    <PMID>20961690</PMID>
  </results_reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 10, 2013</study_first_submitted>
  <study_first_submitted_qc>January 14, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2013</study_first_posted>
  <last_update_submitted>February 20, 2013</last_update_submitted>
  <last_update_submitted_qc>February 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kaohsiung Veterans General Hospital.</investigator_affiliation>
    <investigator_full_name>Kuei-Chang Hsu</investigator_full_name>
    <investigator_title>Consultant Surgeon</investigator_title>
  </responsible_party>
  <keyword>wound healing</keyword>
  <keyword>wound infection</keyword>
  <keyword>pain</keyword>
  <keyword>pruritus</keyword>
  <keyword>cicatrix</keyword>
  <keyword>dressings</keyword>
  <keyword>acticoat absorbent</keyword>
  <keyword>BCT</keyword>
  <keyword>KoCarbonAg</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
    <mesh_term>Pruritus</mesh_term>
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Infective Agents</mesh_term>
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

